Rachel Sampson – Page 3 – Clinical Trial Results

Dr. Erwan Donal and Dr. C Michael Gibson Discuss: Tri.fr trial – Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

August 31, 2024

Disclosures: TBD

Dr. Volker Rudolph, Dr. Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN – Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

August 31, 2024

Disclosures: TBD

Dr. Stefan Anker and Dr. C Michael Gibson Discuss: RESHAPE-HF2 – Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

August 31, 2024

Disclosures: TBD

Dr. Paul Ridker and Dr. C Michael Gibson Discuss: Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a)

August 31, 2024

Disclosures: TBD

Dr. Johanne Silvain, Dr. Gilles Montalescot and Dr. C Michael Gibson Discuss: ABYSS – Beta blocker interruption in post-myocardial infarction patients

August 30, 2024

Disclosures: TBD

Dr. Mikhail Kosiborod and Dr. C Michael Gibson Discuss: Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials

August 30, 2024

Disclosures: TBD

Prevention Town Hall 2024

May 9, 2024

Dr. C. Michael Gibson, Dr. Pam Taub, Dr. Ann Marie Navar present: A Prevention Town Hall: What’s Hot from Recent […]

Dr. Robert Yeh and Dr. C. Michael Gibson Present: AGENT IDE Trial Results

April 3, 2024

Disclosures: TBD

Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial.

February 14, 2024

Disclosures: s/b HeartFlow